Table 3 Material reviewed by type and journal
Material | Journal (N in cohort) | Total (N = 264) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
BMJ (N = 16) | NEJM (N = 55) | Lancet (N = 66) | HTA (N = 127) | |||||||
n | n/N% | n | n/N% | n | n/N% | n | n/N% | n | n/N% | |
Main trial publication | 16 | 100.0 | 55 | 100.0 | 66 | 100.0 | 127 | 100.0 | 264 | 100.0 |
Study protocol as supplementary material | 0 | 0.0 | 50 | 90.9 | 0 | 0.0 | NA | - | 50 | 18.9 |
Other supplementary material excluding study protocol | 5 | 31.3 | 52 | 94.5 | 50 | 75.8 | NA | - | 107 | 40.5 |